Qube Research & Technologies LTD Augmedix, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Augmedix, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 15,433 shares of AUGX stock, worth $35,958. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,433
Previous 222,000
93.05%
Holding current value
$35,958
Previous $907,000
98.57%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AUGX
# of Institutions
60Shares Held
39.6MCall Options Held
19.6KPut Options Held
15K-
Redmile Group, LLC San Francisco, CA16.4MShares$38.2 Million0.94% of portfolio
-
Dcm International Vi, Ltd.4.17MShares$9.71 Million5.31% of portfolio
-
Samjo Capital LLC2.91MShares$6.79 Million5.93% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.85MShares$4.31 Million0.0% of portfolio
-
Perkins Capital Management Inc1.42MShares$3.3 Million1.23% of portfolio
About Augmedix, Inc.
- Ticker AUGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,421,200
- Market Cap $87.2M
- Description
- Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes...